Claire Horvat1, Renee Johnson1, Lien Lam2,3, Jacob Munro4, Francesco Mazzarotto5, Angharad M Roberts5, Daniel S Herman2, Michael Parfenov2, Alireza Haghighi2,3,6, Barbara McDonough2, Steven R DePalma2, Anne M Keogh7,8,9, Peter S Macdonald7,8,9, Christopher S Hayward7,8,9, Amy Roberts10, Paul J R Barton5, Leanne E Felkin5, Eleni Giannoulatou4, Stuart A Cook5,11, J G Seidman2,3, Christine E Seidman2,6, Diane Fatkin12,13,14. 1. Molecular Cardiology Division, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia. 2. Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA. 3. Howard Hughes Medical Institute, Boston, Massachusetts, USA. 4. Molecular, Structural and Computational Biology Division, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia. 5. NIHR Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust, and Imperial College London, London, UK. 6. Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA. 7. Cardiac Physiology and Transplantation Division, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia. 8. Cardiology Department, St Vincent's Hospital, Sydney, New South Wales, Australia. 9. Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia. 10. Boston Children's Hospital, Boston, Massachusetts, USA. 11. Duke-National University of Singapore, and National Heart Center, Singapore, Singapore. 12. Molecular Cardiology Division, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia. d.fatkin@victorchang.edu.au. 13. Cardiology Department, St Vincent's Hospital, Sydney, New South Wales, Australia. d.fatkin@victorchang.edu.au. 14. Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia. d.fatkin@victorchang.edu.au.
Abstract
PURPOSE: We evaluated strategies for identifying disease-causing variants in genetic testing for dilated cardiomyopathy (DCM). METHODS: Cardiomyopathy gene panel testing was performed in 532 DCM patients and 527 healthy control subjects. Rare variants in 41 genes were stratified using variant-level and gene-level characteristics. RESULTS: A majority of DCM cases and controls carried rare protein-altering cardiomyopathy gene variants. Variant-level characteristics alone had limited discriminative value. Differentiation between groups was substantially improved by addition of gene-level information that incorporated ranking of genes based on literature evidence for disease association. The odds of DCM were increased to nearly 9-fold for truncating variants or high-impact missense variants in the subset of 14 genes that had the strongest biological links to DCM (P <0.0001). For some of these genes, DCM-associated variants appeared to be clustered in key protein functional domains. Multiple rare variants were present in many family probands, however, there was generally only one "driver" pathogenic variant that cosegregated with disease. CONCLUSION: Rare variants in cardiomyopathy genes can be effectively stratified by combining variant-level and gene-level information. Prioritization of genes based on their a priori likelihood of disease causation is a key factor in identifying clinically actionable variants in cardiac genetic testing.
PURPOSE: We evaluated strategies for identifying disease-causing variants in genetic testing for dilated cardiomyopathy (DCM). METHODS: Cardiomyopathy gene panel testing was performed in 532 DCM patients and 527 healthy control subjects. Rare variants in 41 genes were stratified using variant-level and gene-level characteristics. RESULTS: A majority of DCM cases and controls carried rare protein-altering cardiomyopathy gene variants. Variant-level characteristics alone had limited discriminative value. Differentiation between groups was substantially improved by addition of gene-level information that incorporated ranking of genes based on literature evidence for disease association. The odds of DCM were increased to nearly 9-fold for truncating variants or high-impact missense variants in the subset of 14 genes that had the strongest biological links to DCM (P <0.0001). For some of these genes, DCM-associated variants appeared to be clustered in key protein functional domains. Multiple rare variants were present in many family probands, however, there was generally only one "driver" pathogenic variant that cosegregated with disease. CONCLUSION: Rare variants in cardiomyopathy genes can be effectively stratified by combining variant-level and gene-level information. Prioritization of genes based on their a priori likelihood of disease causation is a key factor in identifying clinically actionable variants in cardiac genetic testing.
Authors: Jessica R Golbus; Megan J Puckelwartz; John P Fahrenbach; Lisa M Dellefave-Castillo; Don Wolfgeher; Elizabeth M McNally Journal: Circ Cardiovasc Genet Date: 2012-07-04
Authors: Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev Journal: Nat Methods Date: 2010-04 Impact factor: 28.547
Authors: Stephen Pan; Colleen A Caleshu; Kyla E Dunn; Marcia J Foti; Maura K Moran; Oretunlewa Soyinka; Euan A Ashley Journal: Circ Cardiovasc Genet Date: 2012-10-16
Authors: Jan Haas; Karen S Frese; Barbara Peil; Wanda Kloos; Andreas Keller; Rouven Nietsch; Zhu Feng; Sabine Müller; Elham Kayvanpour; Britta Vogel; Farbod Sedaghat-Hamedani; Wei-Keat Lim; Xiaohong Zhao; Dmitriy Fradkin; Doreen Köhler; Simon Fischer; Jennifer Franke; Sabine Marquart; Ioana Barb; Daniel Tian Li; Ali Amr; Philipp Ehlermann; Derliz Mereles; Tanja Weis; Sarah Hassel; Andreas Kremer; Vanessa King; Emil Wirsz; Richard Isnard; Michel Komajda; Alessandra Serio; Maurizia Grasso; Petros Syrris; Eleanor Wicks; Vincent Plagnol; Luis Lopes; Tenna Gadgaard; Hans Eiskjær; Mads Jørgensen; Diego Garcia-Giustiniani; Martin Ortiz-Genga; Maria G Crespo-Leiro; Rondal H Lekanne Dit Deprez; Imke Christiaans; Ingrid A van Rijsingen; Arthur A Wilde; Anders Waldenstrom; Martino Bolognesi; Riccardo Bellazzi; Stellan Mörner; Justo Lorenzo Bermejo; Lorenzo Monserrat; Eric Villard; Jens Mogensen; Yigal M Pinto; Philippe Charron; Perry Elliott; Eloisa Arbustini; Hugo A Katus; Benjamin Meder Journal: Eur Heart J Date: 2014-08-27 Impact factor: 29.983
Authors: Nadine Norton; Peggy D Robertson; Mark J Rieder; Stephan Züchner; Evadnie Rampersaud; Eden Martin; Duanxiang Li; Deborah A Nickerson; Ray E Hershberger Journal: Circ Cardiovasc Genet Date: 2012-02-15
Authors: Trevor J Pugh; Melissa A Kelly; Sivakumar Gowrisankar; Elizabeth Hynes; Michael A Seidman; Samantha M Baxter; Mark Bowser; Bryan Harrison; Daniel Aaron; Lisa M Mahanta; Neal K Lakdawala; Gregory McDermott; Emily T White; Heidi L Rehm; Matthew Lebo; Birgit H Funke Journal: Genet Med Date: 2014-02-06 Impact factor: 8.822
Authors: Ngak-Leng Sim; Prateek Kumar; Jing Hu; Steven Henikoff; Georg Schneider; Pauline C Ng Journal: Nucleic Acids Res Date: 2012-06-11 Impact factor: 16.971
Authors: Christopher M Haggerty; Cynthia A James; Hugh Calkins; Crystal Tichnell; Joseph B Leader; Dustin N Hartzel; Christopher D Nevius; Sarah A Pendergrass; Thomas N Person; Marci Schwartz; Marylyn D Ritchie; David J Carey; David H Ledbetter; Marc S Williams; Frederick E Dewey; Alexander Lopez; John Penn; John D Overton; Jeffrey G Reid; Matthew Lebo; Heather Mason-Suares; Christina Austin-Tse; Heidi L Rehm; Brian P Delisle; Daniel J Makowski; Vishal C Mehra; Michael F Murray; Brandon K Fornwalt Journal: Genet Med Date: 2017-05-04 Impact factor: 8.822
Authors: Christine E Seidman; J G Seidman; Parth N Patel; Kaoru Ito; Jon A L Willcox; Alireza Haghighi; Min Young Jang; Joshua M Gorham; Steven R DePalma; Lien Lam; Barbara McDonough; Renee Johnson; Neal K Lakdawala; Amy Roberts; Paul J R Barton; Stuart A Cook; Diane Fatkin Journal: Circ Genom Precis Med Date: 2021-08-31
Authors: Jay Ramchand; Mathew Wallis; Ivan Macciocca; Elly Lynch; Omar Farouque; Melissa Martyn; Dean Phelan; Belinda Chong; Siobhan Lockwood; Robert Weintraub; Tina Thompson; Alison Trainer; Dominica Zentner; Jitendra Vohra; Michael Chetrit; David L Hare; Paul James Journal: J Am Heart Assoc Date: 2020-01-14 Impact factor: 5.501